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(n= 11). Two networks affirmed conducting studies that were
unfunded or self-funded. Collaborations in critical care have
expanded from activities largely conducted within research
networks to include collaborations between research networks
(Figure 2).
Several key findings arise from our survey. First, research
collaborations in critical care originated from a need for investigators to
work together to advance the science behind caring for critically ill
patients. Second, critical care collaborations largely focus on the design
and implementation of randomized controlled trials. Third, most
critical care research networks developed after 2005. Since this time,
alliances have evolved in scope to include global collaborations
between research networks. Fourth, most critical care research
networks either conduct one or a few large studies or
coordinate multiple research programs concurrently. Fifth,
collaborative critical care research networks depend on peer-reviewed
funding to cover infrastructure costs, with one-fourth of research
networks being self-funded or unfunded. Sixth, financial support for
studies is fragile and dependent on contributions frommultiple funding
partners.
Collaborative research networks have transformed how
critical care research has been conducted over the past three decades.
The future critical care research agenda will be increasingly
accountable to patient and family priorities and societal expectations
for research investments to translate into better health care and
outcomes (8). As the human and financial costs of research increase,
we anticipate greater emphasis on strategies that will simplify the
logistics and costs of conducting critical care research. Novel study
designs and greater collaborations among research networks will be
integral to advancing future research in critical care. n
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Lung and Diaphragm Protection during Noninvasive
Respiratory Support
To the Editor:
We read with interest the article by Grieco and colleagues (1) on the
physiological comparison between high-flow nasal cannula (HFNC)
and noninvasive ventilation (NIV) delivered through the helmet
in patients with acute hypoxic respiratory failure (AHRF). The
optimal noninvasive respiratory support for patients with AHRF is,
indeed, a matter of debate, as we are still far from understanding
all the mechanisms leading to worsening respiratory failure and
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intubation (2). Schematically, treatment should aim at minimizing
the risk of muscular exhaustion leading to rapid shallow
breathing and hypercarbia, while avoiding the risk of additional lung
injury, self-inflicted by high transpulmonary pressure and VT.
Noninvasive respiratory support that grants lung- and diaphragm-
protective ventilation should then be considered as ideal (3, 4).
The authors should be commended for providing a
complete set of physiological data that could enhance our
understanding of the effects of different noninvasive support
in patients with AHRF. Overall, helmet NIV dramatically decreased
the inspiratory effort compared with HFNC. Thus, helmet NIV
could be highly efficient in decreasing the diaphragm workload to a
desired physiological level, able to protect it from myotrauma and
failure (3). On the lung protection side, the authors measured
transpulmonary pressure swings (ΔPL) as a surrogate of dynamic
lung stress during both study phases, reporting nonsignificant
differences between HFNC and helmet NIV (Figure 2 of Reference
1, right upper panel; P= 0.11) (1). The reduction in inspiratory
effort during helmet NIV might have been due to two
different mechanisms: the improvement in respiratory mechanics
because of higher positive end-expiratory pressure effect and/or the
muscles unloading owing to pressure support. For a given VT, with
the first mechanism, the decrease in inspiratory effort (DPES) would
be associated with a decrease in ΔPL (5); on the opposite side,
pressure support could decrease DPES with unchanged (if
mechanics remain stable) or even increased ΔPL (in the presence
of overdistension). Thus, identifying which mechanism is
predominant in each patient might help individualize the type
of support and NIV settings more than looking at average
global values. As an example, it could be interesting to investigate
whether the changes in DPES and ΔPL between HFNC and helmet
NIV were correlated with end-expiratory transpulmonary pressure
during HFNC (6), with subjects with highly negative values
experiencing unchanged or even decreased ΔPL. If this correlation
does exist, helmet NIV would be preferred to HFNC in patients
with very low end-expiratory transpulmonary pressure. The finding
that patients with lower DPES during HFNC increased ΔPL more
during helmet NIV could further corroborate this hypothesis:
indeed, there was no correlation between DPES and
oxygenation during HFNC, suggesting that the major determinant
of respiratory effort is not altered gas exchange, but rather worse
respiratory mechanics and inflammation (4).
The authors also describe that higher ΔPL during helmet NIV was
associated with the need for intubation and with mortality. The latter
is undoubtedly an exploratory analysis, but it is interesting to note that
seven out of eight patients who ultimately required intubation were
clinically supported by helmet NIV for a certain number of hours.
It would be interesting to explore whether this might have
led to higher lung stress and additional lung injury. Additional
explorative analyses could include comparing gas exchange
during the study protocol and the last one measured before
intubation to check whether lung edema worsened or if
derangements of pH and PaCO2 were the main determinants
of intubation.
Already, looking at the results, it seems that the ability to limit
lung stress by helmet NIV might be lower than during HFNC.
Helmet NIV could be considered as step-up support before
intubation only in selected patients or if monitoring confirms
lung-protective conditions. n
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Reply to Spinelli and Mauri
From the Authors:
We read with great interest the letter by Drs. Spinelli and Mauri
discussing our recently published manuscript (1). We are grateful to
the authors for their positive comments, useful suggestions for
further analyses, and brilliant insights regarding interpretation of
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